BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asante EA, Grimshaw A, Smidak M, Jakubcova T, Tomlinson A, Jeelani A, Hamdan S, Powell C, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Collinge J. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS. PLoS Pathog 2015;11:e1004953. [PMID: 26135918 DOI: 10.1371/journal.ppat.1004953] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Mok TH, Nihat A, Majbour N, Sequeira D, Holm-mercer L, Coysh T, Darwent L, Batchelor M, Groveman BR, Orrù CD, Hughson AG, Heslegrave A, Laban R, Veleva E, Paterson RW, Keshavan A, Schott J, Swift IJ, Heller C, Rohrer JD, Gerhard A, Butler C, Rowe JB, Masellis M, Chapman M, Lunn MP, Bieschke J, Jackson G, Zetterberg H, Caughey B, Rudge P, Collinge J, Mead S. Trajectories of neurodegeneration and seed amplification biomarkers prior to disease onset in individuals at risk of prion disease.. [DOI: 10.1101/2022.10.30.22281644] [Reference Citation Analysis]
2 Jackson GS, Linehan J, Brandner S, Asante EA, Wadsworth JDF, Collinge J. Overexpression of mouse prion protein in transgenic mice causes a non-transmissible spongiform encephalopathy. Sci Rep 2022;12:17198. [PMID: 36229637 DOI: 10.1038/s41598-022-21608-3] [Reference Citation Analysis]
3 Manka SW, Wenborn A, Collinge J, Wadsworth JDF. Prion strains viewed through the lens of cryo-EM. Cell Tissue Res 2022. [PMID: 36028585 DOI: 10.1007/s00441-022-03676-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Coysh T, Mead S. The Future of Seed Amplification Assays and Clinical Trials. Front Aging Neurosci 2022;14:872629. [DOI: 10.3389/fnagi.2022.872629] [Reference Citation Analysis]
5 Holec SAM, Woerman AL. Evidence of distinct α-synuclein strains underlying disease heterogeneity. Acta Neuropathol 2021;142:73-86. [PMID: 32440702 DOI: 10.1007/s00401-020-02163-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 20.0] [Reference Citation Analysis]
6 Mok TH, Nihat A, Luk C, Sequeira D, Batchelor M, Mead S, Collinge J, Jackson GS. Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases. Sci Rep 2021;11:5231. [PMID: 33664355 DOI: 10.1038/s41598-021-84527-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Asante EA, Linehan JM, Tomlinson A, Jakubcova T, Hamdan S, Grimshaw A, Smidak M, Jeelani A, Nihat A, Mead S, Brandner S, Wadsworth JDF, Collinge J. Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS. PLoS Biol 2020;18:e3000725. [PMID: 32516343 DOI: 10.1371/journal.pbio.3000725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mok TH, Mead S. Preclinical biomarkers of prion infection and neurodegeneration. Curr Opin Neurobiol 2020;61:82-8. [PMID: 32109717 DOI: 10.1016/j.conb.2020.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Terry C, Wadsworth JDF. Recent Advances in Understanding Mammalian Prion Structure: A Mini Review. Front Mol Neurosci 2019;12:169. [PMID: 31338021 DOI: 10.3389/fnmol.2019.00169] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
10 Rossi M, Baiardi S, Parchi P. Understanding Prion Strains: Evidence from Studies of the Disease Forms Affecting Humans. Viruses 2019;11:E309. [PMID: 30934971 DOI: 10.3390/v11040309] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
11 Gao LP, Shi Q, Xiao K, Wang J, Zhou W, Chen C, Dong XP. The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients. Sci Rep 2019;9:1836. [PMID: 30755683 DOI: 10.1038/s41598-019-38520-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
12 Terry C, Harniman RL, Sells J, Wenborn A, Joiner S, Saibil HR, Miles MJ, Collinge J, Wadsworth JDF. Structural features distinguishing infectious ex vivo mammalian prions from non-infectious fibrillar assemblies generated in vitro. Sci Rep 2019;9:376. [PMID: 30675000 DOI: 10.1038/s41598-018-36700-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
13 Baiardi S, Rossi M, Capellari S, Parchi P. Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol 2019;29:278-300. [PMID: 30588685 DOI: 10.1111/bpa.12695] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
14 Mok TH, Koriath C, Jaunmuktane Z, Campbell T, Joiner S, Wadsworth JDF, Hosszu LLP, Brandner S, Parvez A, Truelsen TC, Lund EL, Saha R, Collinge J, Mead S. Evaluating the causality of novel sequence variants in the prion protein gene by example. Neurobiol Aging 2018;71:265.e1-7. [PMID: 29861043 DOI: 10.1016/j.neurobiolaging.2018.05.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
15 Mercer RCC, Daude N, Dorosh L, Fu ZL, Mays CE, Gapeshina H, Wohlgemuth SL, Acevedo-Morantes CY, Yang J, Cashman NR, Coulthart MB, Pearson DM, Joseph JT, Wille H, Safar JG, Jansen GH, Stepanova M, Sykes BD, Westaway D. A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles. PLoS Pathog 2018;14:e1006826. [PMID: 29338055 DOI: 10.1371/journal.ppat.1006826] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
16 Joiner S, Asante EA, Linehan JM, Brock L, Brandner S, Bellworthy SJ, Simmons MM, Hope J, Collinge J, Wadsworth JDF. Experimental sheep BSE prions generate the vCJD phenotype when serially passaged in transgenic mice expressing human prion protein. J Neurol Sci 2018;386:4-11. [PMID: 29406965 DOI: 10.1016/j.jns.2017.12.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Marino S, Morabito R, De Salvo S, Bonanno L, Bramanti A, Pollicino P, Giorgianni R, Bramanti P. Quantitative, functional MRI and neurophysiological markers in a case of Gerstmann-Sträussler-Scheinker syndrome. Funct Neurol 2017;32:153-8. [PMID: 29042004 DOI: 10.11138/fneur/2017.32.3.153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Bistaffa E, Rossi M, De Luca CMG, Moda F. Biosafety of Prions. Prog Mol Biol Transl Sci 2017;150:455-85. [PMID: 28838674 DOI: 10.1016/bs.pmbts.2017.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, di Domenico A, Vergara C, Hervera A, Sousa A, Fernández-Borges N, Consiglio A, Gavín R, López de Maturana R, Ferrer I, López de Munain A, Raya Á, Castilla J, Sánchez-Pernaute R, Del Río JA. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology. Mol Neurobiol 2018;55:3033-48. [PMID: 28466265 DOI: 10.1007/s12035-017-0506-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
20 Brandner S, Jaunmuktane Z. Prion disease: experimental models and reality. Acta Neuropathol 2017;133:197-222. [PMID: 28084518 DOI: 10.1007/s00401-017-1670-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
21 Moreno J, Telling GC. Transgenic Mouse Models of Prion Diseases. Neuromethods 2017. [DOI: 10.1007/978-1-4939-7211-1_16] [Reference Citation Analysis]
22 Moreno JA, Telling GC. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases. Methods Mol Biol 2017;1658:219-52. [PMID: 28861793 DOI: 10.1007/978-1-4939-7244-9_16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
23 Collinge J. Mammalian prions and their wider relevance in neurodegenerative diseases. Nature 2016;539:217-26. [PMID: 27830781 DOI: 10.1038/nature20415] [Cited by in Crossref: 151] [Cited by in F6Publishing: 156] [Article Influence: 21.6] [Reference Citation Analysis]
24 Huang D, Caflisch A. The roles of the conserved tyrosine in the β2-α2 loop of the prion protein. Prion 2015;9:412-9. [PMID: 26689486 DOI: 10.1080/19336896.2015.1115944] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Eraña H, Venegas V, Moreno J, Castilla J. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins. Biochem Biophys Res Commun 2017;483:1125-36. [PMID: 27590581 DOI: 10.1016/j.bbrc.2016.08.166] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]